Capital expenditure decreased 94.0%
Capital expenditure changed -94.0% from the comparable as-filed period.
$248,000→$15,0002 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →WVE financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Research & development increased 17.4%
Research & development changed +17.4% from the comparable as-filed period.
$45.9M→$53.8M2 prior comparisons
Working capital / assets moved 2582 bp higher
Working capital / assets changed +2582 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
53.69%→79.51%4 prior comparisons
Shares outstanding increased 18.0%
Shares outstanding changed +18.0% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
167,181,784→197,228,9688 prior comparisons
Cash & equivalents increased 0.6%
Cash & equivalents changed +0.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$196.2M→$197.3M4 prior comparisons
Research & development increased 18.0%
Research & development changed +18.0% from the comparable as-filed period.
$43.5M→$51.3M2 prior comparisons
Shares outstanding increased 23.8%
Shares outstanding changed +23.8% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
159,140,460→197,048,1758 prior comparisons
Working capital / assets moved 2785 bp higher
Working capital / assets changed +2785 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
53.95%→81.80%4 prior comparisons
R&D / revenue moved 175791 bp higher
R&D / revenue changed +175791 basis points from the comparable as-filed period.
499.70%→2257.61%2 prior comparisons
Operating cash-flow margin moved 182943 bp lower
Operating cash-flow margin changed -182943 basis points from the comparable as-filed period.
-528.93%→-2358.36%2 prior comparisons
Free-cash-flow margin moved 186482 bp lower
Free-cash-flow margin changed -186482 basis points from the comparable as-filed period.
-532.45%→-2397.27%2 prior comparisons
Receivables / revenue moved 2050 bp higher
Receivables / revenue changed +2050 basis points from the comparable as-filed period.
18.59%→39.08%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.